Amazon deploys its 1 millionth robot

Dear Readers,

With the millionth robot now working for Amazon, something has happened that is easy to overlook - because it seems like a technical detail. But it actually marks a historic turning point: artificial intelligence is leaving the realm of software and becoming a physical force in the world. Machines like “Proteus” or “Pegasus” are no longer prototypes - they act, think and navigate independently. And they are not only changing processes, but the principle of work itself.

At the same time, we are seeing a second, equally revolutionary path: AI is discovering medicines, extending life spans and beginning to define old age itself as a treatable condition. The leap from abstract data to biological effectiveness - as with Rentosertib - shows: We are at the beginning of medical enlightenment 2.0, driven by algorithms.

In Today’s Issue:

All the best,

Amazon has reached a new milestone: over one million robots are now in use in the group's warehouses - bringing the company dangerously close to the threshold where machines outnumber human employees. Amazon currently employs around 1.5 million people, but the automation push is progressing at breathtaking speed.

At the heart of this development is a fleet of smart, AI-controlled machines with names such as “Proteus”, ‘Hercules’ and “Pegasus”. The whole thing is controlled by a system called DeepFleet - a generative AI model that optimizes the robots' movement patterns, similar to autonomous traffic control. According to Amazon, this has shortened the distances in the warehouses by around 10% - saving billions and speeding up processes.

For the AI community, this is both a wake-up call and a promise: the scaling of intelligent systems no longer only works in software, but also affects the real economy. Amazon's example shows how AI can become an industrial backbone - with far-reaching consequences for labor markets, retraining and the role of humans in automated systems.

Why it matters: Amazon's AI fleet is not a pilot project, but shows how AI is reorganizing entire industries - in live operation.

If you want to understand how AI is actually shaping economic reality, you should take a closer look - because this is just the beginning.

Sources:

🔗 https://www.aboutamazon.com/news/operations/amazon-million-robots-ai-foundation-model

🔗 https://www.investopedia.com/amazons-robotic-warehouse-workforce-nears-size-of-human-staff-report-says-11764259

The Rundown is the most trusted AI newsletter in the world, with 1,000,000+ readers and exclusive interviews with AI leaders like Mark Zuckerberg, Demis Hassibis, Mustafa Suleyman, and more.

Their expert research team spends all day learning what’s new in AI and talking with industry experts, then distills the most important developments into one free email every morning.

Plus, complete the quiz after signing up and they’ll recommend the best AI tools, guides, and courses – tailored to your needs.

Sign up to start learning.

A drug developed by Insilico Medicine using generative AI to treat idiopathic pulmonary fibrosis (IPF) has achieved significant improvements in lung capacity in Phase 2a trials in elderly patients. This is the first AI-designed drug to successfully address an organic disease of aging at the human level - a significant milestone towards personalized longevity therapies.

Study in Lifespan.io “Rejuvenation Roundup June 2025”: A single application of a prostaglandin-like lipid metabolite strengthens muscle stem cells in mice after virus exposure and thus promotes functional regeneration in old age. Relevance: opens up ways to combine cell rejuvenation with metabolome modulation and immune response.

A deep learning model estimates vascular age from photoplethysmography data of over 200,000 participants in the UKBiobank dataset. A vascular age increased by ≥9 years doubles the risk of cardiovascular disease and mortality. The breakthrough: non-invasive, scalable via wearables - a milestone for individualized health monitoring and preventive longevity strategies.